Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Clinical Lung Cancer|December 12, 2022
Trends in Stage I Lung CancerAashray Singareddy, Mary Ellen Flanagan, Pamela P Samson, et al.
Cancer Chemotherapy and Pharmacology|March 5, 2022
Phase 1b trial of anti-VEGF/PDGFR vorolanib combined with immune checkpoint inhibitors in patients with advanced solid tumorsNusayba A Bagegni, Haeseong Park, Katlyn Kraft, et al.
NPJ Precision Oncology|October 2, 2023
Pre-radiotherapy ctDNA liquid biopsy for risk stratification of oligometastatic non-small cell lung cancerNicholas P Semenkovich, Shahed N Badiyan, Pamela P Samson, et al.
Research Square|March 30, 2023
Pre-radiotherapy ctDNA liquid biopsy for risk stratification of oligometastatic non-small cell lung cancerNicholas P Semenkovich, Pamela P Samson, Shahed N Badiyan, et al.
Clinical Lung Cancer|July 12, 2023
Association of Molecular Profiles and Mutational Status With Distinct Histological Lung Adenocarcinoma Subtypes. An Analysis of the LACE-Bio DataPrashanth Ashok Kumar, Maryam Karimi, Alina Basnet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2019
Circulating Tumor DNA Profiling in Small-Cell Lung Cancer Identifies Potentially Targetable AlterationsSiddhartha Devarakonda, Sumithra Sankararaman, Brett H Herzog, et al.
Cancer|October 28, 2014
Clinical next-generation sequencing in patients with non-small cell lung cancerIan S Hagemann, Siddhartha Devarakonda, Christina M Lockwood, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 2018
Tumor Mutation Burden as a Biomarker in Resected Non-Small-Cell Lung CancerSiddhartha Devarakonda, Federico Rotolo, Ming-Sound Tsao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2021
Genomic Profiling of Lung Adenocarcinoma in Never-SmokersSiddhartha Devarakonda, Yize Li, Fernanda Martins Rodrigues, et al.
Cancer Cell|June 1, 2020
MYC Drives Temporal Evolution of Small Cell Lung Cancer Subtypes by Reprogramming Neuroendocrine FateAbbie S Ireland, Alexi M Micinski, David W Kastner, et al.
Pageof 5